SEOM clinical guideline for the diagnosis and treatment of gastric cancer (GC) and gastroesophageal junction adenocarcinoma (GEJA) (2019)
Martín-Richard, Marta (Institut d'Investigació Biomèdica Sant Pau)
Carmona-Bayonas, Alberto (Hospital General Universitario Morales Meseguer (Múrcia))
Custodio, A.B. (Centro de Investigación Biomédica en Red de Cáncer)
Gallego, J. (Hospital General Universitario de Elche)
Jiménez-Fonseca, P. (Hospital Universitario Central de Asturias)
Reina, J.J. (Hospital Universitario Virgen Macarena (Sevilla, Andalusia))
Richart, P. (Hospital Universitari i Politècnic La Fe (València))
Rivera, F. (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria))
Alsina, M. (Hospital Universitari Vall d'Hebron)
Sastre Valera, Javier (Hospital Clínico San Carlos (Madrid))
Universitat Autònoma de Barcelona

Date:	2020
Abstract:	Gastric cancer (GC) is the fifth most common cancer worldwide with a varied geographic distribution and an aggressive behavior. In Spain, it represents the sixth cause of cancer death. In Western countries, the incidence is decreasing slightly, with an increase in gastroesophageal junction adenocarcinoma (GEJA), a different entity that we separate specifically in the guideline. Molecular biology advances have been done recently, but do not yet lead to the choice in treatment approach except in advanced disease with overexpression of HER2. Endoscopic resection in very early stage, perioperative chemotherapy in locally advanced tumors and preliminary immune therapy resulting in advanced disease are the main treatment innovations in the GC/GEJA treatment. We describe the different evidences and recommendations following the statements of the American College of Physicians.
Rights:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
Language:	Anglès
Document:	Article ; recerca ; Versió publicada
Subject:	Diagnosis ; Gastric cancer ; Gastroesophageal junction adenocarcinoma ; Treatment
Published in:	Clinical & Translational Oncology, Vol. 22 Núm. 2 (january 2020) , p. 236-244, ISSN 1699-3055

DOI: 10.1007/s12094-019-02259-9
PMID: 31989475

9 p, 740.0 KB

The record appears in these collections:
Research literature > UAB research groups literature > Research Centres and Groups (research output) > Health sciences and biosciences > Institut de Recerca Sant Pau
Articles > Research articles
Articles > Published articles